93 related articles for article (PubMed ID: 9570445)
1. Acute and chronic haemodynamic effects of naftazone in portal hypertensive rats.
Sogni P; Yang S; Pilette C; Moreau R; Gadano A; Avenard G; Bloy C; Lebrec D
Eur J Pharmacol; 1998 Feb; 344(1):37-43. PubMed ID: 9570445
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.
Pilette C; Moreau R; Sogni P; Kirstetter P; Cailmail S; Pussard E; Lebrec D
Eur J Pharmacol; 1996 Sep; 312(1):63-8. PubMed ID: 8891579
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
[TBL] [Abstract][Full Text] [Related]
5. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
[TBL] [Abstract][Full Text] [Related]
6. Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.
Chang CC; Wang SS; Huang HC; Lee JY; Lee FY; Lin HC; Lee SD
J Gastroenterol Hepatol; 2010 Aug; 25(8):1394-400. PubMed ID: 20659229
[TBL] [Abstract][Full Text] [Related]
7. Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats.
Huang HC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Tai CC; Lai IN; Lee SD
J Hepatol; 2004 Feb; 40(2):234-8. PubMed ID: 14739093
[TBL] [Abstract][Full Text] [Related]
8. Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation.
Casadevall M; Piqué JM; Cirera I; Goldin E; Elizalde I; Panés J; Martínez-Cuesta MA; Bosch J; Terés J; Rodés J
Gastroenterology; 1996 Apr; 110(4):1156-65. PubMed ID: 8613005
[TBL] [Abstract][Full Text] [Related]
9. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
10. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
[TBL] [Abstract][Full Text] [Related]
11. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats.
Muñoz J; Albillos A; Pérez-Páramo M; Rossi I; Alvarez-Mon M
Am J Physiol; 1999 Mar; 276(3):G687-93. PubMed ID: 10070045
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: influence in nitric oxide biosynthesis.
Fernández M; García-Pagán JC; Casadevall M; Mourelle MI; Piqué JM; Bosch J; Rodés J
Gastroenterology; 1996 May; 110(5):1529-35. PubMed ID: 8613060
[TBL] [Abstract][Full Text] [Related]
13. Role of nitric oxide and endothelin-1 in a portal hypertensive rat model.
Tsugawa K; Hashizume M; Migou S; Kishihara F; Kawanaka H; Tomikawa M; Tanoue K; Sugimachi K
Scand J Gastroenterol; 2000 Oct; 35(10):1097-105. PubMed ID: 11099065
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
[TBL] [Abstract][Full Text] [Related]
15. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
16. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
[TBL] [Abstract][Full Text] [Related]
17. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats.
Fernández M; García-Pagán JC; Casadevall M; Bernadich C; Piera C; Whittle BJ; Piqué JM; Bosch J; Rodés J
Gastroenterology; 1995 May; 108(5):1487-95. PubMed ID: 7537235
[TBL] [Abstract][Full Text] [Related]
18. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat.
García-Pagán JC; Fernández M; Bernadich C; Pizcueta P; Piqué JM; Bosch J; Rodés J
Am J Physiol; 1994 Dec; 267(6 Pt 1):G984-90. PubMed ID: 7810666
[TBL] [Abstract][Full Text] [Related]
19. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
Wu Y; Burns RC; Sitzmann JV
Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
